Sergio G. Golombek, MD, MPH, FAAP is a Professor of Pediatrics and Clinical Public
Health at the New York Medical College and an Attending Neonatologist at The Regional
Neonatal Center, Maria Fareri Children’s Hospital at Westchester Medical Center, in
Valhalla, NY. He received his medical degree from the University of Buenos Aires
School of Medicine, Argentina. After training in pediatrics and neonatology in Argentina,
he moved to the US, where he completed a pediatric residency at the R. Blank Memorial
Hospital for Children at Iowa Methodist Medical Center in Des Moines, Iowa, followed by
a Fellowship in Neonatal-Perinatal medicine at The Children’s Mercy Hospital in Kansas
City, Missouri. He is Board Certified in Pediatrics and Neonatal-Perinatal Medicine. He is
an active member of the American Academy of Pediatrics (representative to the
Executive Committee of the Section of Perinatal Pediatrics), SIBEN - the Iberoamerican
Society of Neonatology (President-Elect), the Society for Pediatric Research and the
American Pediatric Society. In 2004 he received his MPH (International Health) from the
School of Public Health at New York Medical College. He is the current Chairman of the
IRB at New York Medical College. He is the Past President of the New York Perinatal
Society (2006-2009).
He has received the Physician Recognition Award from the American Medical
Association since 1993; was included in “Who’s Who in Medicine and Healthcare”,
Millennium Edition (2000), and has been consistently listed in “Guide to America’s Top
Pediatricians”, “Who’s Who in American Education”, and New York and Westchester’s
Best Doctors.
He has been involved with several multicenter trials since 1996 while a full-time
academic faculty at the State University of New York at Stony Brook and now at the
Children’s Hospital at Westchester Medical Center. He was the site co-PI for the study
“Early non-tidal vs. tidal ventilation study in very low birth weight infants”, and the site PI
for the NHLBI Study #U01-HL62514-01A1: Low dose inhaled nitric oxide for prevention
and treatment of chronic lung disease in the preterm infant (Dr. Roberta Ballard’s NO
CLD study) which resulted in a multiple reports including one in the New England
Journal of Medicine. He is also involved in other clinical research, experimental design
and analysis activities in the fellowship training program. He has been involved in the
planning, design and successful completion of the THOP 1 pilot study published in
Pediatrics.
Dr. Golombek was an the Associate editor of Neoreviews en Español; currently
he is in the Editorial Board of NeoReviews and the Journal of Perinatology; he has
published on the diagnosis and treatment of transient hypothyroxinemia of prematurity,
RSV prophylaxis, and use of inhaled nitric oxide in newborns. Additionally, he has edited
and contributed chapters to Augusto Sola’s textbook “Special Care of the Fetus and
Newborn: Physiopathology and Therapeutics,” and to the 6th and 7th Edition of
“Neonatology: Pathophysiology and Management of the Newborn”, edited by Gordon B.
Avery, Mary Ann Fletcher and Mhairi G. MacDonald, including “Principles of respiratory
care and strategies for management”.